Document Detail

MedLine Citation:
PMID:  9125619     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Cocaine-associated morbidities in pregnant women (e.g., abruptio placentae, hypertension, seizures) occur mostly during the final stages of gestation. The purpose of our study was to determine whether cocaine's toxicity and blood levels varied as a function of "critical periods" of exposure during gestation. STUDY DESIGN: To evaluate mortality rates, pregnant Long-Evans rats received subcutaneously 30, 40, or 50 mg/kg cocaine hydrochloride twice daily (C30, C40, and C50 groups) either during gestational days 7 to 13 (midgestation) or gestational days 14 to 20 (late gestation) (n 9 to 20 per group). Serum levels of the cocaine metabolite benzoylecgonine were examined in other groups of rats on either gestational day 13 (mid) or day 20 (late) in the C30 treatment condition (n = 5 and 10 per group). RESULTS: There were no maternal mortalities in the midgestation groups at any dose. In contrast, the late-gestation groups showed a dramatic dose-dependent effect, with maternal mortality rates of 0%, 40%, and 72% in the C30, C40, and C50 groups. The late-gestation group had higher benzoylecgonine levels than the midgestation groups did. CONCLUSIONS: Late gestation was associated with higher maternal mortality rates and higher benzoylecgonine levels, indicating that some underlying physiologic change enhanced cocaine's toxicity as pregnancy progressed. This increased sensitivity to cocaine may be mediated by estrogen or progesterone, suggesting that the cocaine-abusing woman is at increased risk for cocaine-induced morbidities whenever levels of these hormones are elevated, such as during the final stages of pregnancy or possibly when taking oral contraceptives.
M W Church; M G Subramanian
Related Documents :
7218129 - An mmpi typology of male alcoholics: admission, discharge and outcome comparisons.
2115099 - Workshop on the qualitative and quantitative comparability of human and animal developm...
12019589 - Female fertility in relation to the consumption of fish contaminated with persistent or...
24675769 - Measurement of fetal abdominal and subscapular subcutaneous tissue thickness during pre...
11226039 - Anatomical and histological changes in the oviducts of japanese quail, coturnix japonic...
24636399 - Miscarriage chromosome testing: utility of comparative genomic hybridization with refle...
23132119 - Environmental risk factors and perinatal outcomes in preterm newborns, according to fam...
571359 - Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinem...
17978129 - Placenta-derived, cellular messenger rna expression in the maternal blood of preeclampt...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  176     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1997 Apr 
Date Detail:
Created Date:  1997-05-13     Completed Date:  1997-05-13     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  901-6     Citation Subset:  AIM; IM    
Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cocaine / analogs & derivatives,  blood,  toxicity*
Dose-Response Relationship, Drug
Gestational Age
Pregnancy, Animal / blood,  drug effects*
Grant Support
Reg. No./Substance:
50-36-2/Cocaine; 519-09-5/benzoylecgonine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Progesterone up-regulates vasodilator effects of calcitonin gene-related peptide in N(G)-nitro-L-arg...
Next Document:  Maternal and perinatal long-chain fatty acids: possible roles in preterm birth.